Structure-Activity Relationships and Drug Design
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Dosage Regimens: Designs and Approaches
Dosage Regimen: Individualization
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Classification
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 7, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
Jung-Hsin Lin1, Alexander L Perryman, Julie R Schames
1Howard Hughes Medical Institute, Department of Chemistry & Biochemistry, and Department of Pharmacology, University of California at San Diego, 92093-0365, USA. jlin@maccammon.ucsd.edu
A new computational drug design method, "relaxed-complex," accounts for receptor flexibility. It identifies optimal ligand-enzyme binding modes, enabling potent drug development.
10:01Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: